144 related articles for article (PubMed ID: 12066956)
21. In vivo release of beta human chorionic gonadotropin by luteinizing hormone releasing hormone stimulation and its clinical application as a remission criterion in patients with gestational trophoblastic disease.
Kim SJ; Jung JK; Kang BC; Namkoong SE; Lee JW
Int J Gynaecol Obstet; 1988 Oct; 27(2):193-8. PubMed ID: 2460385
[TBL] [Abstract][Full Text] [Related]
22. Vascular patterns of gestational trophoblastic tumors by color Doppler ultrasound.
Hsieh FJ; Wu CC; Lee CN; Chen TM; Chen CA; Chen FC; Chen CL; Hsieh CY
Cancer; 1994 Oct; 74(8):2361-5. PubMed ID: 7522951
[TBL] [Abstract][Full Text] [Related]
23. Recurrence of metastatic trophoblastic disease after negative, plasma human chorionic gonadotropin beta-subunit assay.
McComb P; Ho Yuen B; Boyes D; White G
Gynecol Oncol; 1980 Feb; 9(1):114-6. PubMed ID: 6243596
[No Abstract] [Full Text] [Related]
24. The use of ultrasound in the evaluation of trophoblastic disease and its response to therapy.
Requard CK; Mettler FA
Radiology; 1980 May; 135(2):419-222. PubMed ID: 6245429
[TBL] [Abstract][Full Text] [Related]
25. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
[TBL] [Abstract][Full Text] [Related]
26. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease.
Khoo SK; Daunter B
Aust N Z J Obstet Gynaecol; 1980 Feb; 20(1):35-42. PubMed ID: 6248013
[TBL] [Abstract][Full Text] [Related]
27. Pregnancy beta1 glycoprotein and chorionic gonadotrophin in the serum of patients with trophoblastic and non-trophoblastic tumours.
Bagshawe KD; Lequin RM; Sizaret PH
Eur J Cancer (1965); 1978 Dec; 14(12):1331-5. PubMed ID: 83941
[No Abstract] [Full Text] [Related]
28. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
Jones WB; Lehr M; Lewis JL
Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
[No Abstract] [Full Text] [Related]
29. Gestational trophoblastic neoplasia: diagnosis with Doppler US.
Taylor KJ; Schwartz PE; Kohorn EI
Radiology; 1987 Nov; 165(2):445-8. PubMed ID: 2821575
[TBL] [Abstract][Full Text] [Related]
30. Non-resolution of pelvic sonographic abnormality after chemotherapy for persistent trophoblastic disease--a word of caution.
Woo JS; Ngan HY; Ma HK
Eur J Obstet Gynecol Reprod Biol; 1986 Jul; 22(3):153-6. PubMed ID: 3015700
[TBL] [Abstract][Full Text] [Related]
31. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
[TBL] [Abstract][Full Text] [Related]
32. New criteria for the diagnosis of gestational trophoblastic disease.
Romero R; Horgan JG; Kohorn EI; Kadar N; Taylor KJ; Hobbins JC
Obstet Gynecol; 1985 Oct; 66(4):553-8. PubMed ID: 2995891
[TBL] [Abstract][Full Text] [Related]
33. Evolving concepts of molar pregnancy.
Berkowitz RS; Goldstein DP; Bernstein MR
J Reprod Med; 1991 Jan; 36(1):40-4. PubMed ID: 1848899
[TBL] [Abstract][Full Text] [Related]
34. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
Cole LA; Kohorn EI; Kim GS
J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
[TBL] [Abstract][Full Text] [Related]
35. HCG tests in the management of gestational trophoblastic diseases.
Cole LA; Sutton JM
Clin Obstet Gynecol; 2003 Sep; 46(3):523-40. PubMed ID: 12972735
[No Abstract] [Full Text] [Related]
36. Beta-hCG vs intact hCG assays in the detection of trophoblastic disease.
Rinker AD; Tietz NW
Clin Chem; 1989 Aug; 35(8):1799-800. PubMed ID: 2474392
[TBL] [Abstract][Full Text] [Related]
37. The utility of a rapid assay for human chorionic gonadotropin in the management of trophoblastic disease.
Soules MR; Tyrey L; Hammond CB
Am J Obstet Gynecol; 1979 Oct; 135(3):384-92. PubMed ID: 225953
[TBL] [Abstract][Full Text] [Related]
38. Use of an immunoradiometric assay and a radioimmunoassay for the detection of free beta-human chorionic gonadotropin.
Shapiro AI; Wu TF; Ballon SC; Lamb EJ
Obstet Gynecol; 1985 Apr; 65(4):545-9. PubMed ID: 2580254
[TBL] [Abstract][Full Text] [Related]
39. Are serum inhibin concentrations new markers of placental tumours in the course of chemotherapy?
Pautier P; Ghione S; Brailly-Tabard S; Lhommé C; Morice P; Bidart JM
Hum Reprod; 2001 Nov; 16(11):2434-7. PubMed ID: 11679534
[TBL] [Abstract][Full Text] [Related]
40. HCG--choosing the best assay to monitor gestational trophoblastic disease and other germ cell tumours.
Evans BD; Harvey VJ; Knox BS; Duff G
N Z Med J; 1993 Jun; 106(958):261. PubMed ID: 8392672
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
